AI Summary & Key Takeaways
AI InsightCONCLUSION: We concluded that the procedure should be reserved for patients with subinvoluted uterus, ultrasonographic evidence of intrauterine tumor, abnormal or persistent uterine bleeding and elevated hCG values. (Gynecol Obstet Reprod Med 1997; 3:442-444)
📌 3 Key Takeaways
Abstract
OBJECTIVE: The purpose of this paper was to assess the advantages and disadvantages of a repeat curettage and verify a diagnosis of malignant disease in patients with hydatidiform mole. STUDY DESİGN: One hundred one patients with hydatidiform mole admitted to Dr. Zekai Tahir Burak Women's Hospital between 1995 and 1997, underwent a repeat uterine curettage approximately one week after a molar evacuation. The pathology reports of each patient were reconsidered and the relationship between the histological findings was analysed. RESULT: In only one (1.04%) of these curettages was a diagnosis of choriocarsinoma established. This study showed that evolution of malignancy after hydatidiform mole was rarely proven-by routine repeat curettage. . . CONCLUSION: We concluded that the procedure should be reserved for patients with subinvoluted uterus, ultrasonographic evidence of intrauterine tumor, abnormal or persistent uterine bleeding and elevated hCG values. (Gynecol Obstet Reprod Med 1997; 3:442-444)
Özet
OBJECTIVE: The purpose of this paper was to assess the advantages and disadvantages of a repeat curettage and verify a diagnosis of malignant disease in patients with hydatidiform mole. STUDY DESİGN: One hundred one patients with hydatidiform mole admitted to Dr. Zekai Tahir Burak Women's Hospital between 1995 and 1997, underwent a repeat uterine curettage approximately one week after a molar evacuation. The pathology reports of each patient were reconsidered and the relationship between the histological findings was analysed. RESULT: In only one (1.04%) of these curettages was a diagnosis of choriocarsinoma established. This study showed that evolution of malignancy after hydatidiform mole was rarely proven-by routine repeat curettage. . . CONCLUSION: We concluded that the procedure should be reserved for patients with subinvoluted uterus, ultrasonographic evidence of intrauterine tumor, abnormal or persistent uterine bleeding and elevated hCG values. (Gynecol Obstet Reprod Med 1997; 3:442-444)